Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Provided By GlobeNewswire
Last update: Oct 13, 2025
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET
- Poster presentation on preclinical evaluation of petosemtamab on cancer stem cells: Friday, October 24 12:30-4:00 p.m. ET
94.83
-0.02 (-0.02%)
Find more stocks in the Stock Screener
MRUS Latest News and Analysis
